EMA Authorised: Insulatard (Insulin human) — Novo Nordisk A/S

View source ↗

Summary

Authorised status for Insulatard (insulin human) from Novo Nordisk A/S for diabetes mellitus in the European market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulatard (insulin isophane)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Novo Nordisk A/S. Decision date: 24/09/2020